Terms: = Skin cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Treatment
406 results:
1. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
3. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
[TBL] [Abstract] [Full Text] [Related]
4. ATF5 promotes malignant T cell survival through the PI3K/AKT/mtor pathway in cutaneous T cell lymphoma.
Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
[TBL] [Abstract] [Full Text] [Related]
5. Loureirin A Promotes Cell Differentiation and Suppresses Migration and Invasion of Melanoma Cells via WNT and AKT/mtor Signaling Pathways.
Xia ZY; Liu L; Kuok CF; Wang XL; Shi D; Ma Q; Cheng XY; Wang GL; Li MJ; Zheng QS; Liu XN; Li DF; Li BH
Biol Pharm Bull; 2024 Feb; 47(2):486-498. PubMed ID: 38199251
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and spectrum of infectious and inflammatory dermatologic conditions occurring in pediatric heart transplant patients on a predominantly mtor-based immune suppressive regimen: A retrospective chart review.
Rydberg A; Ameduri R; Brown T; Johnson JN; Todd A; Tollefson MM; Anderson K
Pediatr Transplant; 2024 Feb; 28(1):e14664. PubMed ID: 38149373
[TBL] [Abstract] [Full Text] [Related]
7. β-endorphin suppresses ultraviolet B irradiation-induced epidermal barrier damage by regulating inflammation-dependent mtorC1 signaling.
Kim HS; Kim HJ; Hong YD; Son ED; Cho SY
Sci Rep; 2023 Dec; 13(1):22357. PubMed ID: 38102220
[TBL] [Abstract] [Full Text] [Related]
8. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
10. Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.
He Y; Wang X
Comput Biol Med; 2023 Dec; 167():107591. PubMed ID: 37875043
[TBL] [Abstract] [Full Text] [Related]
11. Piperlongumine induces apoptosis via the MAPK pathway and ERK‑mediated autophagy in human melanoma cells.
Jeon SJ; Choi EY; Han EJ; Lee SW; Moon JM; Jung SH; Jung JY
Int J Mol Med; 2023 Dec; 52(6):. PubMed ID: 37830157
[TBL] [Abstract] [Full Text] [Related]
12. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract] [Full Text] [Related]
13. Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mtor signaling.
Dong Y; Cao X; Huang J; Hu Z; Chen C; Chen M; Long Q; Xu Z; Lv D; Rong Y; Luo S; Wang H; Deng W; Tang B
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166887. PubMed ID: 37739092
[TBL] [Abstract] [Full Text] [Related]
14. Kuwanon H Inhibits Melanoma Growth through Cytotoxic Endoplasmic Reticulum Stress and Impaired Autophagy Flux.
Hu X; Pan G; Luo J; Gao X; Mu Y; Wang Z; Hu X; Li C; Abbas MN; Zhang K; Zheng Y; Cui H
J Agric Food Chem; 2023 Sep; 71(37):13768-13782. PubMed ID: 37672659
[TBL] [Abstract] [Full Text] [Related]
15. Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa.
Petrasca A; Hambly R; Kearney N; Smith CM; Pender EK; Mac Mahon J; O'Rourke AM; Ismaiel M; Boland PA; Almeida JP; Kennedy C; Zaborowski A; Murphy S; Winter D; Kirby B; Fletcher JM
Br J Dermatol; 2023 Nov; 189(6):730-740. PubMed ID: 37648653
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.
Aoude LG; Brosda S; Ng J; Lonie JM; Belle CJ; Patel K; Koufariotis LT; Wood S; Atkinson V; Smithers BM; Pearson JV; Waddell N; Barbour AP; Bonazzi VF
J Mol Diagn; 2023 Oct; 25(10):771-781. PubMed ID: 37544359
[TBL] [Abstract] [Full Text] [Related]
17. Antioxidant, antitumoral, antimetastatic effect and inhibition of collagenase enzyme activity of Eleutherine bulbosa (Dayak onion) extract: In vitro, in vivo and in silico approaches.
Silva RMGD; Alves CP; Barbosa FC; Santos HH; Adão KM; Granero FO; Figueiredo CCM; Figueiredo CR; Nicolau-Junior N; Silva LP
J Ethnopharmacol; 2024 Jan; 318(Pt B):117005. PubMed ID: 37544339
[TBL] [Abstract] [Full Text] [Related]
18. mtor Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells.
Dewaele S; Delhaye L; De Paepe B; Bogaert B; Martinez R; Anckaert J; Yigit N; Nuytens J; Van Coster R; Eyckerman S; Raemdonck K; Mestdagh P
Nucleic Acid Ther; 2023 Aug; 33(4):248-264. PubMed ID: 37389884
[TBL] [Abstract] [Full Text] [Related]
19. A Review of Topical Sirolimus for the treatment of Facial Angiofibromas in Tuberous Sclerosis Complex.
Dao DD; Pixley JN; Akkurt ZM; Feldman SR
Ann Pharmacother; 2024 Apr; 58(4):428-433. PubMed ID: 37386842
[TBL] [Abstract] [Full Text] [Related]
20. The PI3K-Akt-mtor and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds.
Roy T; Boateng ST; Uddin MB; Banang-Mbeumi S; Yadav RK; Bock CR; Folahan JT; Siwe-Noundou X; Walker AL; King JA; Buerger C; Huang S; Chamcheu JC
Cells; 2023 Jun; 12(12):. PubMed ID: 37371141
[TBL] [Abstract] [Full Text] [Related]
[Next]
